Alio Medical, a San Francisco, CA-based wearable technology company enabling insights through clinical grade real-time data, closed a $20m Series B financing round.
The round, which included the conversion of all previously issued convertible notes, was led by Thomas Krebs, former Treasurer of Penumbra Inc., and by Zekavat Investment Group.
The company will use the funding to conduct clinical studies on expanded indications and support the platform’s initial commercialization, as well as expand its enterprise partnerships within the United States and Europe.
Led by David Kuraguntla, CEO, Alio is a wearable technology company enabling insights through clinical grade real-time data. Its primary monitoring platform, powered by the SmartPatch, connects other clinical grade sensors through proprietary technology.
In addition, the company announced that Kenneth Zekavat, President of Zekavat Investment Group, and Eric Hargan, former deputy Deputy Secretary of Health and Human Services, would immediately join Alio’s board of directors as new directors.
FinSMEs
01/07/2021